Navigation Links
Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
Date:5/25/2010

NEW YORK, May 25 /PRNewswire/ -- Phreesia, the leading patient check-in company, announced today the close of a $16 million Series D investment. Ascension Health Ventures (AHV) led the round, joining existing investors BlueCross BlueShield Venture Partners, L.P., Sandbox Industries, Polaris Venture Partners, HLM Venture Partners, and Long River Ventures. As part of the investment, Victor Kats, Investment Manager at Ascension Health Ventures, will be joining Phreesia's board of directors.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100525/NY07290 )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080220/NYW106LOGO )

"We're excited to have AHV leading this round. AHV is a strategic venture fund investing on behalf of four of the largest not-for-profit health systems in the country. Working with a fund like AHV that shares our mission to provide patient-centered care is important for Phreesia," said Phreesia's CEO and co-founder, Chaim Indig. "This investment will enable Phreesia to continue to expand its presence in the healthcare market so as to provide additional clinical value and increase revenue for clinicians across all 50 states."

Phreesia's technology platform automates the patient check-in process in thousands of physician offices and urgent care centers in the U.S. Its wireless touchscreen pads are used by patients to verify and update demographic and insurance information and provide valuable clinical information that seamlessly integrates into existing practice management and electronic health record systems. Physicians and other stakeholders are able to communicate and engage with patients at the time of care based on the medical condition(s) reported during the check-in process.

Victor Kats at AHV said, "This investment reinforces our belief that Phreesia is addressing a significant need for improved capture of clinical and demographic information at the point of care. By giving providers access to clinical tools that help meet emerging "meaningful use" requirements and that share vital patient information across venues of care, Phreesia is adding value for multiple stakeholders. We're proud to partner with an innovative and fast-growing healthcare company such as Phreesia."

Established in 2001 by Ascension Health, AHV closed a second fund in 2007 with $200 million in commitments from Ascension Health, Catholic Health East, Catholic Health Initiatives and Catholic Healthcare West. These health systems serve their communities through over 200 acute care hospitals and hundreds of outpatient facilities across 38 states and the District of Columbia.

About Ascension Health Ventures

Ascension Health Ventures was launched in 2001 as a wholly-owned subsidiary of Ascension Health. AHV's role has been to construct and manage a strategic portfolio of investments that deliver a venture investment return, have the potential to transform the healthcare industry and significantly enhance the quality of patient care. CHV II, LP, a limited partnership between Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West, has been formed to expand this strategic investment initiative to other Catholic healthcare systems. AHV is the general partner of CHV II, LP.

About Phreesia

Phreesia is the national leader in patient check-in. By automating patient intake, Phreesia allows medical practices to conveniently collect patient information and payments. Phreesia delivers fully interactive content direct-to-patients and is designed to interface with clinicians' existing and future technology. Phreesia is committed to enhancing the patient experience and enabling clinicians to stay at the forefront of patient care. For more information visit www.phreesia.com.


'/>"/>
SOURCE Phreesia
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
5. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
6. Reduced Lung Capacity Accelerates With Diabetes
7. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
8. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
9. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
10. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
11. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... YORK , Feb. 23, 2017 /PRNewswire/ ... comprehensive insights on the various drugs being ... report covers all the drugs that are ... & Clinical). The pipeline focuses on novel ... molecules, antibodies, stem cell therapies, recombinant proteins ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) today announced ... Directors that will be submitted to the 2017 Annual ... the company,s three largest shareholders at the end of ... seat on the Nomination Committee, and the Chairman of ... was as follows:  Anders ...
Breaking Medicine Technology:
(Date:2/23/2017)... Boston, MA (PRWEB) , ... February 23, 2017 ... ... Education and Department of Justice jointly issued a letter to withdraw ... in accordance with their gender identity. The guidance issued in May 2016 by ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Development will host a diverse symposium on “Doping in Sport: How ... and Sheppard Mullin Richter & Hampton LLP. The symposium will be held at ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, ... trials, today announced that Premier Research, a leading clinical development service provider, has ... are becoming increasingly complex, due in part to an array of circumstances including ...
Breaking Medicine News(10 mins):